Does ETOPOSIDE Cause Diffuse large b-cell lymphoma recurrent? 375 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 375 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with ETOPOSIDE (Avopef). This represents 0.7% of all adverse event reports for ETOPOSIDE.
375
Reports of Diffuse large b-cell lymphoma recurrent with ETOPOSIDE
0.7%
of all ETOPOSIDE reports
61
Deaths
70
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From ETOPOSIDE?
Of the 375 reports, 61 (16.3%) resulted in death, 70 (18.7%) required hospitalization, and 19 (5.1%) were considered life-threatening.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ETOPOSIDE. However, 375 reports have been filed with the FAERS database.
What Other Side Effects Does ETOPOSIDE Cause?
Off label use (6,495)
Febrile neutropenia (5,966)
Disease progression (3,776)
Drug ineffective (3,687)
Neutropenia (3,641)
Thrombocytopenia (3,085)
Product use in unapproved indication (2,774)
Anaemia (2,586)
Pyrexia (2,453)
Sepsis (2,211)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
RITUXIMAB (1,359)
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
DOXORUBICIN (953)
PREDNISONE (738)
CYTARABINE (406)
DEXAMETHASONE (402)
CISPLATIN (306)
GEMCITABINE (280)
BENDAMUSTINE (255)
Which ETOPOSIDE Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
ETOPOSIDE vs ETORICOXIB
ETOPOSIDE vs ETRASIMOD ARGININE
ETOPOSIDE vs ETRAVIRINE
ETOPOSIDE vs EUCALYPTOL\MENTHOL\METHYL SALICYLATE\THYMOL
ETOPOSIDE vs EVEROLIMUS